GlaxoSmithKline Turns To AI For Drug Development

GSK AI Drug Development The Pharma giant- GlaxoSmithKline is ramping
up its use of artificial intelligence & would be recruiting 80
Artificial Intelligence specialists by the end of 2020. However, the
UK's largest drugmaker by revenue is struggling to hire Artificial
Intelligence scientists & engineers from areas such as Silicon Valley.
Therefore as an alternative, the drugmaker […]

The post GlaxoSmithKline Turns To AI For Drug Development appeared
first on BioTecNika .

https://www.biotecnika.org/2019/12/glaxosmithkline-turns-to-ai-for-drug-development/

Biotech News

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Politics of Making Poverty Visible in Brazil and Mexico